JPM Thematics - Genetic Therapies D (acc) - EUR (hedged)
LU2091933452
JPM Thematics - Genetic Therapies D (acc) - EUR (hedged)/ LU2091933452 /
| NAV30/05/2024 |
Chg.+0.3800 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
| 72.5900EUR |
+0.53% |
reinvestment |
Equity
Worldwide
|
JPMorgan AM (EU) ▶ |
Stratégie d'investissement
To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
Will invest in equities of companies that have been identified by the Investment Manager as being involved in research, development, production or marketing of genetic therapies and their associated businesses anywhere in the world, including emerging markets. The Investment Manager supervises and monitors the theme identification and portfolio construction process and actively selects securities for the Sub-Fund"s portfolio. At least 90% of companies purchased will be analysed against the theme.
Objectif d'investissement
To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
Opérations
| Type de rendement: |
reinvestment |
| Fonds Catégorie: |
Equity |
| Région de placement: |
Worldwide |
| Branche: |
Sector Health / Pharma |
| Benchmark: |
MSCI All Country World Index (Total Return Net) |
| Début de l'exercice: |
01/07 |
| Dernière distribution: |
- |
| Banque dépositaire: |
J.P. Morgan SE - Zweigniederlassung Luxemburg |
| Domicile: |
Luxembourg |
| Permission de distribution: |
Austria, Germany, Switzerland, Luxembourg |
| Gestionnaire du fonds: |
Yazann Romahi, Aijaz Hussain |
| Actif net: |
588.01 Mio.
USD
|
| Date de lancement: |
19/12/2019 |
| Focus de l'investissement: |
- |
Conditions
| Surtaxe d'émission: |
5.00% |
| Frais d'administration max.: |
0.72% |
| Investissement minimum: |
5,000.00 EUR |
| Deposit fees: |
- |
| Frais de rachat: |
0.50% |
| Prospectus simplifié: |
Télécharger (Version imprimée) |
Actifs
| Stocks |
|
99.37% |
| Mutual Funds |
|
0.63% |
Pays
| United States of America |
|
76.62% |
| Switzerland |
|
8.07% |
| Japan |
|
5.63% |
| Germany |
|
2.30% |
| Australia |
|
1.91% |
| France |
|
1.31% |
| China |
|
1.00% |
| Taiwan, Province Of China |
|
0.72% |
| Netherlands |
|
0.66% |
| Korea, Republic Of |
|
0.62% |
| Singapore |
|
0.32% |
| United Kingdom |
|
0.24% |
| Autres |
|
0.60% |
Branches
| Pharma/Biotechnology |
|
87.07% |
| Healthcare services |
|
11.49% |
| Healthcare appliances |
|
0.78% |
| Autres |
|
0.66% |
